Astellas and Cullgen enter inks agreement to advance innovative targeted protein degraders
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Convergent action on AMR identified as an important area of intervention
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Construction will begin this year with the new capacity anticipated by 2025
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
Subscribe To Our Newsletter & Stay Updated